Hepatocyte proliferation and hepatitis C virus kinetics during treatment.
作者信息
Dahari H, Rong L, Layden T J, Cotler S J
出版信息
Clin Pharmacol Ther. 2011 Mar;89(3):353-4. doi: 10.1038/clpt.2010.238. Epub 2011 Jan 26.
Abstract
摘要
相似文献
1
Hepatocyte proliferation and hepatitis C virus kinetics during treatment.
Clin Pharmacol Ther. 2011 Mar;89(3):353-4. doi: 10.1038/clpt.2010.238. Epub 2011 Jan 26.
2
An ODEs multiscale model with cell proliferation for hepatitis C virus infection treated with direct acting antiviral agents.
J Biol Dyn. 2024 Dec;18(1):2423956. doi: 10.1080/17513758.2024.2423956. Epub 2024 Nov 13.
3
Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
J Theor Biol. 2010 Dec 7;267(3):330-40. doi: 10.1016/j.jtbi.2010.08.036. Epub 2010 Sep 8.
4
Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systems.
Antiviral Res. 2019 Sep;169:104537. doi: 10.1016/j.antiviral.2019.104537. Epub 2019 Jun 14.
5
Continued value in understanding viral kinetic decline during interferon-free therapy for HCV.
Liver Int. 2015 Feb;35(2):295-6. doi: 10.1111/liv.12748.
6
Curcumin against hepatitis C virus infection: spicing up antiviral therapies with 'nutraceuticals'?
Gut. 2014 Jul;63(7):1035-7. doi: 10.1136/gutjnl-2013-305646. Epub 2013 Oct 3.
7
Hepatitis C viral kinetic models.
Cell Death Differ. 2003 Jan;10 Suppl 1:S7-8. doi: 10.1038/sj.cdd.4401118.
8
Mathematical modeling of HCV infection and treatment.
Methods Mol Biol. 2009;510:439-53. doi: 10.1007/978-1-59745-394-3_33.
9
3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV.
Biochem Biophys Res Commun. 2009 Feb 6;379(2):330-4. doi: 10.1016/j.bbrc.2008.12.054. Epub 2008 Dec 25.
10
Lycorine-derived phenanthridine downregulators of host Hsc70 as potential hepatitis C virus inhibitors.
Future Med Chem. 2015;7(5):561-70. doi: 10.4155/fmc.15.14.
引用本文的文献
1
Modelling hepatitis C therapy--predicting effects of treatment.
Nat Rev Gastroenterol Hepatol. 2015 Aug;12(8):437-45. doi: 10.1038/nrgastro.2015.97. Epub 2015 Jun 30.
2
Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B.
Curr Hepat Rep. 2011 Jul 2;10(3):214-227. doi: 10.1007/s11901-011-0101-7.
本文引用的文献
1
A comprehensive hepatitis C viral kinetic model explaining cure.
Clin Pharmacol Ther. 2010 Jun;87(6):706-13. doi: 10.1038/clpt.2010.35. Epub 2010 May 12.
2
Rapid emergence of protease inhibitor resistance in hepatitis C virus.
Sci Transl Med. 2010 May 5;2(30):30ra32. doi: 10.1126/scitranslmed.3000544.
3
Volumetric and functional recovery of the liver after right hepatectomy for living donation.
Liver Transpl. 2004 Aug;10(8):1024-9. doi: 10.1002/lt.20182.
4
Liver regeneration and surgical outcome in donors of right-lobe liver grafts.
Transplantation. 2003 Jul 15;76(1):5-10. doi: 10.1097/01.TP.0000079064.08263.8E.
5
Liver regeneration.
Science. 1997 Apr 4;276(5309):60-6. doi: 10.1126/science.276.5309.60.
Zotero 插件